Press release
Renal Denervation Systems Market Size Worth US$ 1,723.6 Million by 2027 | CAGR 40.67%
Renal Denervation Systems Market Report
Report Highlights
How big is the renal denervation systems market?
The global renal denervation systems market size reached US$ 218.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,723.6 Million by 2027, exhibiting a growth rate (CAGR) of 40.67% during 2022-2027.
What is renal denervation systems?
Renal denervation (RDN) refers to a minimally invasive,catheter-based procedure that is performed to treat resistant hypertension. It involves a radiofrequency ablation, which burns the nerves within the renal arteries. This, in turn, suppresses the nerve activity and modulates the output of the sympathetic nerves, thereby assisting in decreasing the blood pressure. In addition to this, it lowers renin secretion, improves blood flow, and stimulates natriuresis. Consequently, RDN systems is being widely adopted to treat hypertension coexisting with metabolic abnormalities, sleep apnea, heart failure, chronic kidney disease, and arrhythmias.
Request for a free sample copy of this report: https://www.imarcgroup.com/renal-denervation-systems-market/requestsample
What are the growth prospects and trends in the renal denervation systems industry?
The global RDN systems market is majorly being driven by the growing instances of lifestyle-related disorders, such as therapy-resistant hypertension, due to sedentary lifestyle, evolving dietary habits, and the increasing cigarette smoking population. This is further supported by the rising geriatric population, which is more susceptible to developing such ailments. Moreover, the growingawareness regarding the clinical advantages associated with RDN systems, including quick recovery, cost-effectiveness, and minimal complications are also facilitating the product demand across the globe. Other than this, continuous investments in research and development (R&D) activities to introduce alternative technologies for RDN, such as micro-infusion, is acting as another growth-inducing factor. Additionally, increasing clinical trials to validate clinical efficiency of RDN over conventional surgeries are creating a positive outlook for the market further. Looking forward, the market is expected to grow at a CAGR of 40.67% during 2022-2027.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product Type:
Catheters
Single Electrode Catheter
Multi Electrode Catheter
RF Generator
Nerve Modifying Agents
Breakup by Product:
Symplicity
Vessix (V2)
EnligHTN
Paradise
Iberis
Others
Breakup by Technology:
Ultrasound Ablation
Radiofrequency Ablation
Microinfusion
Breakup by Application:
Hypertension
Cardiac Disorders
Diabetes
Renal Failure
Others
Breakup by End User:
Diagnostic Centers and Hospitals
Ambulatory Care Centers
Others
Breakup by Region:
North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Boston Scientific Group
Kona Medical Inc.
Medtronic Plc
Mercator MedSystems
ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
Renal Dynamics
St. Jude Medical Inc. (Abbott)
Terumo Corporation.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2558&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Renal Denervation Systems Market Size Worth US$ 1,723.6 Million by 2027 | CAGR 40.67% here
News-ID: 3040741 • Views: …
More Releases from IMARC Group
Start Your Six Sigma Consulting Practice: Step-by-Step Business Plan & Growth Op …
Overview
IMARC Group's "Six Sigma Consulting Business Plan and Project Report 2025" provides a structured roadmap for establishing a successful Six Sigma and process improvement consulting business. This comprehensive report analyzes market trends, operational frameworks, investment requirements, revenue models, and financial forecasts, making it a valuable resource for entrepreneurs, management consultants, industrial firms, and investors.
Whether launching a new Six Sigma consulting practice or expanding an existing quality and operational excellence firm,…
Vietnam Herbal Tea Market 2026 - Top Regions, Latest Technology, Investment Oppo …
The Vietnam Herbal Tea Market reached a market size of USD 16.45 Million in 2025 and is projected to grow to USD 26.46 Million by 2034. Exhibiting a CAGR of 5.42% during the forecast period from 2026 to 2034, the market growth is driven by increasing health and wellness awareness among Vietnamese consumers, the expansion of digital commerce platforms improving accessibility, and the adoption of sustainable and organic tea production…
Vietnam Green Hydrogen Market Outlook: Trends, Growth, and Future Opportunities …
The Vietnam green hydrogen market reached a size of USD 6.75 Million in 2024 and is forecasted to grow to USD 215.20 Million by 2033. This growth corresponds to a CAGR of 46.92% during the forecast period 2025-2033. Favorable factors include abundant renewable energy resources, government policy support, and increasing demand from industrial and transport sectors. Technological advancements and international collaborations further bolster market expansion.
Sample Request Link: https://www.imarcgroup.com/vietnam-green-hydrogen-market/requestsample
Study Assumption Years
Base…
Switzerland Watch Market to Hit USD 947.11 Million by 2033 with a Robust CAGR of …
The Switzerland watch market size reached USD 649.52 Million in 2024 and is expected to grow to USD 947.11 Million by 2033, exhibiting a CAGR of 4.28% during the forecast period 2025-2033. The market is driven by precision craftsmanship, luxury branding, and changing consumer preferences, with focus on both mechanical and smartwatches. Distribution via retail and e-commerce has enhanced accessibility while customization and sustainability are gaining importance among consumers.
Sample Request…
More Releases for Renal
Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market?
The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors…
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032.
Renal Osteodystrophy Market Overview
The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early…
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development…
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market?
The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in…
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period…
